(Q33347074)

26 July 2017

title

Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis (English)

1 reference

autoimmune thrombocytopenic purpura

26 July 2017

1 reference

1 reference

6

Pierre Fenaux

1 reference

26 July 2017

5

0 references

author name string

Emmanuelle Bourgeois

1

1 reference

26 July 2017

Marie T Caulier

2

1 reference

26 July 2017

Catherine Delarozee

3

1 reference

26 July 2017

Marc Brouillard

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

British Journal of Haematology

26 July 2017

published in

1 reference

26 July 2017

volume

120

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

1079-1088

1 reference

Slow infusion of vinca alkaloids in the treatment of idiopathic thrombocytopenic purpura

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Low-dose danazol therapy in idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Recombinant human interferon alpha-2b (rh IFN alpha-2b) therapy for steroid resistant idiopathic thrombocytopenic purpura (ITP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Management of splenectomy failures in chronic immune thrombocytopenic purpura: role of accessory splenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Treatment of autoimmune thrombopenic purpura in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Autoimmune (idiopathic) thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Therapy for adults with refractory chronic immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04211.X

10.1046/J.1365-2141.2003.04211.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference